Parallel Advisors, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2021$10,000
+100.0%
2,0000.0%0.00%
Q1 2021$5,0000.0%2,0000.0%0.00%
Q4 2020$5,000
+66.7%
2,0000.0%0.00%
Q3 2020$3,0000.0%2,0000.0%0.00%
Q2 2020$3,0000.0%2,0000.0%0.00%
Q1 2020$3,000
-50.0%
2,0000.0%0.00%
Q4 2019$6,000
-85.0%
2,000
-96.8%
0.00%
-100.0%
Q3 2019$40,000
-34.4%
63,090
+0.1%
0.00%
-50.0%
Q2 2019$61,000
-29.9%
63,0000.0%0.01%
-40.0%
Q1 2019$87,00063,0000.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders